Vanderbilt's PREDICT Program Adds PGx Testing for Transplant Rejection Drug GenomeWeb Since adding a new immunosuppressive drug, called tacrolimus, to its pharmacogenetics program earlier this year, Vanderbilt University's doctors have used the school's electronic medical records to identify several thousand patients who harbor gene ... |
